SURI
Simplify Propel Opportunities ETF
1W: -3.5%
1M: -3.6%
3M: -1.8%
YTD: -2.6%
1Y: +9.4%
3Y: +18.9%
$16.13
+0.50 (+3.19%)
After Hours: $14.58 (-1.54, -9.58%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$72M
Holdings37
Top 10 Wt69.7%
Beta1.29
% Profitable12%
Coverage91%
Portfolio Valuation
P/E14.0
P/B3.0
P/S0.1
EV/EBITDA5.5
P/FCF2.4
PEG1.00
Profitability & Returns
Gross Margin7.2%
Net Margin0.5%
ROE11.6%
ROA0.7%
ROIC11.9%
Div Yield2.85%
Leverage & Liquidity
Debt/Equity6.08
Debt/Assets0.36
Net Debt/EBITDA3.4x
Interest Cov4.2x
Current Ratio1.07
Quick Ratio1.03
Growth (YoY)
Revenue+28.4%
Net Income+69.4%
EPS+76.1%
FCF+3.5%
EBITDA+0.1%
Rev CAGR 3Y+27.0%
Quality Scores
Piotroski F4.6
Altman Z2.95
IS Quality43.3
IS Overall37.9
IS Value51.2
Median P/E-3.3
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 36 | 53.2% | -1.8 |
| Energy | 1 | 40.3% | 18.7 |
| Other | 13 | 6.5% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 50 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | PLAINS GP HLDGS L P | PAGP | 40.31% | $30.2M | 1,272,360 | 18.7 | $4.8B | Energy |
| 2 | ACHIEVE LIFE SCIENCES INC USD 0.001 | ACHV | 6.47% | $4.8M | 1,184,512 | -2.8 | $150M | Healthcare |
| 3 | PHATHOM PHARMACEUTICALS USD 0.0001 | PHAT | 4.02% | $3.0M | 270,031 | -3.6 | $825M | Healthcare |
| 4 | MILESTONE PHARMACEUTICALS INC NPV | MIST | 3.42% | $2.6M | 1,506,405 | -1.6 | $106M | Healthcare |
| 5 | DELCATH SYS INC USD 0.01 | DCTH | 3.26% | $2.4M | 261,126 | 122.8 | $320M | Healthcare |
| 6 | ABEONA THERAPEUTICS INC USD 0.01 | ABEO | 3.04% | $2.3M | 500,342 | 3.2 | $252M | Healthcare |
| 7 | Cash Cash | — | 2.96% | $2.2M | 2,212,218 | — | — | — |
| 8 | CELLDEX THERAPEUTICS INC USD 0.001 | CLDX | 2.77% | $2.1M | 68,994 | -8.2 | $2.1B | Healthcare |
| 9 | OCULIS HOLDING AG CHF 0.01 | OCS | 2.26% | $1.7M | 66,667 | -11.2 | $1.4B | Healthcare |
| 10 | VIRIDIAN THERAPEUTICS INC USD 0.01 | VRDN | 2.09% | $1.6M | 56,231 | -7.0 | $2.4B | Healthcare |
| 11 | KYVERNA THERAPEUTICS IN USD 0.00001 | KYTX | 2.08% | $1.6M | 181,908 | -2.2 | $345M | Healthcare |
| 12 | INVENTIVA SA NPV ADR | IVA | 2.01% | $1.5M | 249,442 | -1.8 | $313M | Healthcare |
| 13 | LEONABIO INC USD 0.0001 | LONA | 1.98% | $1.5M | 149,279 | — | $36M | Healthcare |
| 14 | CORCEPT THERAPEUTICS INC USD 0.001 | CORT | 1.72% | $1.3M | 37,763 | 40.2 | $4.3B | Healthcare |
| 15 | ACHIEVE LIFE SCIENCES I WTS 30JUN30 Private | — | 1.41% | $1.1M | 966,667 | — | — | — |
| 16 | ORCHESTRA BIOMED HLDGS I USD 0.0001 | OBIO | 1.36% | $1.0M | 219,387 | -3.3 | $267M | Healthcare |
| 17 | AQUESTIVE THERAPEUTICS IN USD 0.001 | AQST | 1.27% | $951,173 | 234,279 | -6.0 | $418M | Healthcare |
| 18 | COMPASS PATHWAYS PLC USD 0.008 ADR | CMPS | 1.22% | $911,368 | 159,052 | -1.8 | $540M | Healthcare |
| 19 | ZEVRA THERAPEUTICS INC USD 0.0001 | ZVRA | 1.21% | $904,712 | 96,246 | 6.3 | $536M | Healthcare |
| 20 | 4D MOLECULAR THERAPEUTIC USD 0.0001 | FDMT | 1.20% | $897,623 | 99,958 | -4.2 | $504M | Healthcare |
| 21 | TELSAT 5.625 12/06/26 144A Corp Private | — | 1.09% | $816,875 | 1,000,000 | — | — | — |
| 22 | SAB BIOTHERAPEUTICS INC USD 0.0001 | SABS | 1.00% | $750,837 | 198,634 | 5.6 | $37M | Healthcare |
| 23 | OCULAR THERAPEUTIX INC USD 0.0001 | OCUL | 0.99% | $744,300 | 90,000 | -6.8 | $1.8B | Healthcare |
| 24 | EYEPOINT INC | EYPT | 0.99% | $738,124 | 53,526 | -4.7 | $1.1B | Healthcare |
| 25 | VOR BIOPHARMA INC USD 0.0001 | VOR | 0.94% | $704,727 | 53,510 | -0.0 | $89M | Healthcare |
| 26 | TREVI THERAPEUTICS INC USD 0.001 | TRVI | 0.94% | $699,908 | 65,412 | -41.1 | $1.5B | Healthcare |
| 27 | PALISADE BIO INC USD 0.01 | PALI | 0.93% | $696,500 | 350,000 | -6.5 | $298M | Healthcare |
| 28 | UPSTREAM BIO INC USD 0.001 | UPB | 0.87% | $651,905 | 77,793 | -4.3 | $512M | Healthcare |
| 29 | ZEALAND PHARMA A/S DKK 1.0 | ZLDPF | 0.86% | $645,283 | 14,894 | 3.1 | $3.1B | Healthcare |
| 30 | KALARIS THERAPEUTICS INC USD 0.0001 | KLRS | 0.80% | $595,371 | 87,426 | -3.1 | $114M | Healthcare |
| 31 | COHERUS ONCOLOGY INC USD 0.0001 | CHRS | 0.78% | $580,901 | 360,808 | 1.2 | $207M | Healthcare |
| 32 | IMMUNIC INC USD 0.0001 | IMUX | 0.68% | $509,161 | 438,932 | -20.5 | $130M | Healthcare |
| 33 | AKERO THERAPEUTICS INC CVR Private | — | 0.57% | $426,634 | 145,609 | — | — | — |
| 34 | LENZ THERAPEUTICS INC N USD 0.00001 | LENZ | 0.55% | $410,526 | 35,729 | -3.3 | $284M | Healthcare |
| 35 | WTS - MILESTONE PHARMACEUTICALS INC SERIES A Private | — | 0.49% | $368,595 | 1,842,974 | — | — | — |
| 36 | OVID THERAPEUTICS INC USD 0.001 | OVID | 0.40% | $300,870 | 130,813 | -11.4 | $171M | Healthcare |
| 37 | CORVUS PHARMACEUTICALS I USD 0.0001 | CRVS | 0.38% | $285,210 | 20,242 | -72.6 | $1.2B | Healthcare |
| 38 | NUVATION BIO INC USD 0.0001 | NUVB | 0.26% | $197,464 | 46,353 | -7.4 | $1.5B | Healthcare |
| 39 | CONNECT BIOPHARMA HOLD USD 0.000174 | CNTB | 0.22% | $166,873 | 58,144 | -5.7 | $188M | Healthcare |
| 40 | ARTIVA BIOTHERAPEUTICS I USD 0.0001 | ARTV | 0.17% | $128,230 | 23,230 | -1.6 | $135M | Healthcare |
| 41 | SATELLOS BIOSCIENCE INC NPV | MSLE | 0.02% | $12,063 | 1,506 | — | $9M | Healthcare |
| 42 | CONTRA CHINOOK THERAPE + NPV Private | — | 0.00% | $2,500 | 25,000 | — | — | — |
| 43 | EIGER BIOPHARMACEUTICALS USD 0.0001 | EIGRQ | 0.00% | $900 | 90,000 | -0.2 | $13M | Healthcare |
| 44 | WTS - MILESTONE PHARMACEUTICALS INC SERIES B Private | — | 0.00% | $2 | 1,842,974 | — | — | — |
| 45 | JASPER THERAPEUTIC WTS Private | — | 0.00% | $1 | 609,053 | — | — | — |
| 46 | WTS - TENAYA THERAPEUTICS INC Private | — | 0.00% | $1 | 560,000 | — | — | — |
| 47 | WTS - QUOIN PHARMACEUTICALS LTD - Series I Private | — | —% | $0 | 34,895 | — | — | — |
| 48 | WTS - QUOIN PHARMACEUTICALS LTD - Series K Private | — | —% | $0 | 34,895 | — | — | — |
| 49 | WTS - QUOIN PHARMACEUTICALS LTD - Series J Private | — | —% | $0 | 34,895 | — | — | — |
| 50 | WTS - QUOIN PHARMACEUTICALS LTD - Series H Private | — | —% | $0 | 34,895 | — | — | — |